Concentrate AI launched a HIPAA-compliant AI gateway for healthcare and life sciences companies. The gateway provides access to leading AI models through a single API and business associate agreement. Monthly access costs US$499, and inference is billed at provider rates without token markups.
Supported models
The gateway supports OpenAI GPT and Anthropic Claude models, plus Google Gemini through Vertex AI. It also supports open-weight alternatives for suitable workloads. These options can reduce inference costs by up to 70% depending on performance and latency requirements.
Company traction
Concentrate AI has processed hundreds of millions of requests and trillions of tokens since its June 2026 launch. Its platform supports customers including Brilliant, Nextiva, Pocket, Proximal, and Tiger Data. More than a dozen healthcare companies now use it, including Kinstead and Hummingbird Healthcare.
Security and governance
The platform includes managed LLM operations, spend management tools, observability, and enterprise governance. It carries a SOC 2 Type II report and offers role-based access controls, single sign-on, and zero-data-retention endpoints. The gateway also provides multi-cloud resiliency for production workloads.
The healthcare gateway is available to any organization that handles PHI or PII. Concentrate AI is based in New York City. Model coverage is limited to supported inference routes and configurations.